Anesthesia and analgesia · 2026
Management of Direct Oral Anticoagulants in Adult Patients Undergoing Cardiac Surgery: A Joint Consensus Statement by the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons.
СтатьяConsensus StatementСистематический обзорКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Budd Ashley N, Kertai Miklos D, Wyler von Ballmoos Moritz C, Raphael Jacob, Ghadimi Kamrouz, Levy Jerrold H, Shore-Lesserson Linda J, Mazzeffi Michael A, Sniecinski Roman M, Tanaka Kenichi A, Bolliger Daniel, Abdalla Mohamed, Ural Kelly G, Upchurch Patrick A, Rozental Olga, Hunter Caroline B, Seibert Adam R, Klick John C, Carroll David, Lobner Katie, Hensley Nadia B
Аннотация
The Society of Cardiovascular Anesthesiologists (SCA) along with the Society of Thoracic Surgeons (STS) sought to improve the care of adult patients undergoing cardiac surgery who are taking direct oral anticoagulants (DOACs), such as factor Xa and direct thrombin inhibitors. To fulfill this, a systematic review of the literature on cessation of DOACs before cardiac surgery, options for monitoring DOACs, the need for bridging, reversal agents, and resuming the medications after surgery was performed. Additionally, an expert consensus around the management of these patients was completed. Summary statements were created using evidence and expert consensus to guide care of patients in each of these domains, with the ultimate goal to enhance patient safety and outcomes.